Jerald Korn (’03) joins Kaleido Biosciences, Inc. as general counsel and corporate secretary
LEXINGTON, Mass., July 22, 2019 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today announced the appointment of Jerald Korn (’03) as General Counsel and Corporate Secretary, reporting to President and Chief Executive Officer, Alison Lawton.
“Jerald brings an in-depth understanding of strategy and operations in growth-stage organizations and more than 15 years of experience guiding the executive teams of some of the leading public life science companies,” said Alison Lawton, President and Chief Executive Officer of Kaleido. “As we continue to advance our business, Kaleido will benefit from Jerald’s proven success helping companies navigate expansion, transactions and commercializing products that can improve patients’ lives. We’re thrilled to have him on our team.”